Go Pro
→ The window is closing (From American Alternative) (Ad)tc pixel Free BVC Stock Alerts

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 13.93 -0.32 (-2.23%)
As of 04:43 AM Eastern
Compare

BVC vs. TSTL, SPEC, AKR, ODX, and CNSL

Should you buy BATM Advanced Communications stock or one of its competitors? MarketBeat compares BATM Advanced Communications with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Omega Diagnostics Group (ODX), and Cambridge Nutritional Sciences (CNSL). These companies are all part of the "medical instruments & supplies" industry.

How does BATM Advanced Communications compare to Tristel?

BATM Advanced Communications (LON:BVC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

In the previous week, Tristel had 1 more articles in the media than BATM Advanced Communications. MarketBeat recorded 1 mentions for Tristel and 0 mentions for BATM Advanced Communications. BATM Advanced Communications' average media sentiment score of 0.00 equaled Tristel'saverage media sentiment score.

Company Overall Sentiment
BATM Advanced Communications Neutral
Tristel Neutral

Tristel has lower revenue, but higher earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A
Tristel£49.54M3.63£6.54M£16.2423.09

Tristel has a net margin of 15.88% compared to BATM Advanced Communications' net margin of -14.90%. Tristel's return on equity of 23.64% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
Tristel 15.88%23.64%9.89%

16.6% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 21.6% of Tristel shares are held by institutional investors. 31.0% of BATM Advanced Communications shares are held by insiders. Comparatively, 21.0% of Tristel shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

BATM Advanced Communications has a beta of 0.754, suggesting that its share price is 25% less volatile than the broader market. Comparatively, Tristel has a beta of 0.339, suggesting that its share price is 66% less volatile than the broader market.

Summary

Tristel beats BATM Advanced Communications on 9 of the 12 factors compared between the two stocks.

How does BATM Advanced Communications compare to INSPECS Group?

INSPECS Group (LON:SPEC) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

In the previous week, INSPECS Group's average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
INSPECS Group Neutral
BATM Advanced Communications Neutral

INSPECS Group has a net margin of -2.67% compared to BATM Advanced Communications' net margin of -14.90%. INSPECS Group's return on equity of -6.07% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
INSPECS Group-2.67% -6.07% 0.45%
BATM Advanced Communications -14.90%-22.13%0.58%

0.4% of INSPECS Group shares are held by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are held by institutional investors. 19.6% of INSPECS Group shares are held by insiders. Comparatively, 31.0% of BATM Advanced Communications shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

BATM Advanced Communications has lower revenue, but higher earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than BATM Advanced Communications, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INSPECS Group£191.70M0.55-£4.11M-£9.40N/A
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A

INSPECS Group has a beta of 1.607, suggesting that its stock price is 61% more volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, suggesting that its stock price is 25% less volatile than the broader market.

INSPECS Group currently has a consensus target price of GBX 60, suggesting a potential downside of 38.14%. Given INSPECS Group's stronger consensus rating and higher possible upside, research analysts plainly believe INSPECS Group is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

INSPECS Group beats BATM Advanced Communications on 8 of the 14 factors compared between the two stocks.

How does BATM Advanced Communications compare to Akers Biosciences?

Akers Biosciences (LON:AKR) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, dividends and earnings.

Akers Biosciences has higher earnings, but lower revenue than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Akers Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Akers Biosciences£2.32M0.00N/A-£129.60N/A
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A

In the previous week, Akers Biosciences' average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
Akers Biosciences Neutral
BATM Advanced Communications Neutral

16.6% of BATM Advanced Communications shares are held by institutional investors. 31.0% of BATM Advanced Communications shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Akers Biosciences has a net margin of 0.00% compared to BATM Advanced Communications' net margin of -14.90%. Akers Biosciences' return on equity of 0.00% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
Akers BiosciencesN/A N/A N/A
BATM Advanced Communications -14.90%-22.13%0.58%

Summary

BATM Advanced Communications beats Akers Biosciences on 5 of the 8 factors compared between the two stocks.

How does BATM Advanced Communications compare to Omega Diagnostics Group?

Omega Diagnostics Group (LON:ODX) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

In the previous week, Omega Diagnostics Group's average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
Omega Diagnostics Group Neutral
BATM Advanced Communications Neutral

Omega Diagnostics Group has a beta of 3.85, meaning that its stock price is 285% more volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, meaning that its stock price is 25% less volatile than the broader market.

BATM Advanced Communications has higher revenue and earnings than Omega Diagnostics Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Omega Diagnostics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omega Diagnostics Group£7.55M0.00-£3.17M-£0.01N/A
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A

BATM Advanced Communications has a net margin of -14.90% compared to Omega Diagnostics Group's net margin of -51.15%. BATM Advanced Communications' return on equity of -22.13% beat Omega Diagnostics Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Omega Diagnostics Group-51.15% -29.14% -10.53%
BATM Advanced Communications -14.90%-22.13%0.58%

29.8% of Omega Diagnostics Group shares are held by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are held by institutional investors. 50.6% of Omega Diagnostics Group shares are held by company insiders. Comparatively, 31.0% of BATM Advanced Communications shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

BATM Advanced Communications beats Omega Diagnostics Group on 6 of the 10 factors compared between the two stocks.

How does BATM Advanced Communications compare to Cambridge Nutritional Sciences?

BATM Advanced Communications (LON:BVC) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

BATM Advanced Communications has a beta of 0.754, meaning that its stock price is 25% less volatile than the broader market. Comparatively, Cambridge Nutritional Sciences has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market.

In the previous week, BATM Advanced Communications' average media sentiment score of 0.00 equaled Cambridge Nutritional Sciences'average media sentiment score.

Company Overall Sentiment
BATM Advanced Communications Neutral
Cambridge Nutritional Sciences Neutral

Cambridge Nutritional Sciences has a net margin of 16.94% compared to BATM Advanced Communications' net margin of -14.90%. Cambridge Nutritional Sciences' return on equity of 12.15% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
Cambridge Nutritional Sciences 16.94%12.15%-2.36%

16.6% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 1.6% of Cambridge Nutritional Sciences shares are held by institutional investors. 31.0% of BATM Advanced Communications shares are held by company insiders. Comparatively, 7.8% of Cambridge Nutritional Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

BATM Advanced Communications has higher revenue and earnings than Cambridge Nutritional Sciences. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.38-£278.26K-£4.20N/A
Cambridge Nutritional Sciences£8.06M0.49-£3.03M£0.602.76

Summary

Cambridge Nutritional Sciences beats BATM Advanced Communications on 6 of the 11 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

Export
MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£47.38M£2.91B£6.96B£2.78B
Dividend Yield3.52%1.91%2.68%6.12%
P/E Ratio-3.3217.4727.19368.16
Price / Sales0.38106.86574.5584,675.62
Price / Cash2.12146.5449.2527.89
Price / Book0.602.5210.857.59
Net Income-£278.26K£99.80M£3.59B£5.89B
7 Day Performance-3.92%0.03%-1.94%0.12%
1 Month Performance-2.23%3.21%2.20%-1.28%
1 Year Performance-9.53%-4.23%23.81%62.28%

BATM Advanced Communications Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 13.93
-2.2%		N/A-7.6%£47.38M£123.20MN/A980
TSTL
Tristel
N/AGBX 390
-0.6%		N/A-6.9%£187.19M£49.54M24.01208
SPEC
INSPECS Group
N/AGBX 97
flat		GBX 60
-38.1%		+110.1%£105.90M£191.70MN/A1,673
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32MN/A120
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55MN/A91

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:BVC) was last updated on 7/17/2026 by MarketBeat.com Staff.
From Our Partners
The window is closing
We printed 1,000 copies of this report and 688 are gone—when the last one goes out, we're pulling it offline b...
American Alternative | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel